Norfolk Southern Corporation vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Norfolk Southern Corporation trades at $326.37 (market cap $72.13B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Norfolk Southern Corporation is far larger — about 6.7× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Norfolk Southern Corporation pays the higher dividend (1.68%). Which is the better fit depends on your goals — on Pluang, investors hold Norfolk Southern Corporation for 34 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| NSC | RDY | |
|---|---|---|
Market Cap | $72.13B | $10.78B |
Volume | 650,750 | 2,724,343 |
Sector | Industrials | Health |
52-Week High | $352.98 | $15.38 |
52-Week Low | $278.19 | $11.38 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $87.68B | $10.68B |
Dividend Yield | 1.68% | 0.65% |
Signals from Pluang's Aura AI — not financial advice
Norfolk Southern (NSC) trades at $321.14, up 0.56% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (21.02% net margin). Recent news highlights momentum for the Union Pacific merger, while institutional buying and a $361.86 consensus price target suggest upside potential.
Outlook remains positive with merger progress and dividend stability, but risks include fuel cost pressures and regulatory hurdles. The current valuation (P/E 27.4) demands execution on freight share gains and merger benefits to justify further gains.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →